GlassScriptPhysician profile
Stephanie Lao
NPI 1073011169
$1,566.67
in general payments reported to CMS, 2019-2025
26 companies · $79.55 in 2025
The $79.55 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.73 · 2020: $81.54 · 2021: $688 · 2022: $249 · 2023: $327 · 2024: $105 · 2025: $79.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $484.40 | 2020-2023 | |
| Myovant Sciences INC. | $140.25 | 2021 | |
| Daiichi Sankyo INC. | $128.35 | 2021-2022 | |
| Hologic Sales and Service, LLC | $78.03 | 2022-2024 | Aptima |
| Therapeuticsmd, INC. | $76.66 | 2020-2022 | |
| Roche Diagnostics Corporation | $69.07 | 2021 | |
| Evofem Biosciences, INC. | $63.35 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.53 | 2020-2022 | |
| Organon LLC | $53.17 | 2021-2023 | Nexplanon |
| Exeltis, USA INC. | $39.00 | 2022-2024 | Slynd |
| Coopersurgical, INC. | $38.10 | 2023-2025 | Endosee, Paragard T 380a |
| Coloplast Corp | $37.92 | 2021-2024 | |
| Ge Healthcare | $37.73 | 2019 | |
| Pfizer INC. | $31.35 | 2021-2023 | |
| Biogen, INC. | $28.71 | 2025 | Zurzuvae |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $28.51 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $27.96 | 2021 | |
| Boston Scientific Corporation | $24.20 | 2023 | Ekosonic |
| Intuitive Surgical, INC. | $22.76 | 2020 | |
| Shield Therapeutics INC | $19.87 | 2022 | |
| Sumitomo Pharma America, INC. | $19.41 | 2023 | Myfembree |
| Agile Therapeutics, INC. | $17.50 | 2021 | |
| Corium, LLC | $16.98 | 2024 | Azstarys |
| Dysis Medical, INC. | $11.72 | 2021 | |
| Aspira Women'S Health INC | $6.34 | 2024 | Ova1 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Lao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.